Get started Log in

PNT — POINT Biopharma Global News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Market Cap
$1.33bn
Enterprise Value
$998.03m
Revenue
$226.58m

Brief: POINT Biopharma Posts Q4 Net Loss USD 14.2 Mln

POINT Biopharma Global

27/03/2023 13:15

Mar 27 (Reuters) - POINT Biopharma :
* Q4 net income USD -14.2 million.
* Q4 EPS USD -0.16

Recent news on POINT Biopharma Global

Brief: Eli Lilly Completes Acquisition Of POINT Biopharma
27/12/2023 13:34
Fusion Pharma gains on Bristol Myers-RayzeBio deal
26/12/2023 19:27
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
26/12/2023 11:18
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
20/12/2023 22:52
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower
18/12/2023 19:22